Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorNew Valley University
About this trial
To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing urethral stricture recurrence after direct visual internal urethrotomy.
Eligibility criteria
Qualifiers
Age ≥ 18 years
American Society of Anesthesiologists (ASA) score ≤3.
Urethral stricture length ≤ 1.5 cm
Disqualifiers
Recurrent urethral stricture ≥ 2 times.
Pelvic fracture urethral distraction defect (PFUDD).
Trial design
Treatments tested in this trial
- Nonsteroidal anti-inflammatory drugs
- Placebo
Treatment groups
82 Participants
are divided into 2 treatment groupsLocations
1New Valley University72511, New ValleyNew Valley Governorate, Egypt
Sponsors and collaborators
New Valley University
Lead sponsor
Source ClinicalTrials.gov